Comparison of the dissolution of metaxalone tablets (Skelaxin) using USP apparatus 2 and 3

AAPS PharmSciTech

Volumn 5, Issue 1, 2004, Pages

  Cacace, Janice ^a   Reilly, Eugene E ^b   Amann, Anton ^c  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b Pharma Quality Services Inc   (United States)

^c ACN Pharma LLC   (United States)

Author keywords

Apparatus 3; Dissolution; Metaxalone; pH dependence

Indexed keywords

METAXALONE; OXAZOLIDINONE DERIVATIVE;

ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DRUG DOSAGE FORM; DRUG SOLUBILITY; PH; TABLET FORMULATION; CHEMISTRY; PHARMACEUTICS; SOLUBILITY; TABLET;

DELAYED-ACTION PREPARATIONS; HYDROGEN-ION CONCENTRATION; OXAZOLIDINONES; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 23144440784     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1007/bf02830574     Document Type: Article

References (8)

1. Bruce RB, Turnbull L, Newman J, Pitts J. Metabolism of metaxalone. J Med Chem. 1966;9(3):286-288.
2. Harden RN, Argoff C. A review of three commonly prescribed skeletal muscle relaxants. J Back Musculoskeletal Rehabil. 2000;15(2-3):63-66.
3. Pfeifer MA, Ross DR, Schrage JP, Gelber DA, Schumer MP, Crain GM, Markwell SS, Jung S. A highly successful and novel model for the treatment of chronic painful diabetic neuropathy. Diabetes Care. 1993;16(8):1103-1115.
4. Spierings EL. Chronic daily headache: a review. Headache Quarterly. 2000;11(3):181-196.
5. Ward TN. Providing relief from headache: current options for acute and prophylactic treatment. Postgrad Med. 2000;108(3):121-128.
6. Rxlist 2002. Metaxalone Monograph. Available at: http://www.rxlist.com. Accessed April 2001.
7. Saife M, Shah J, inventors; Assigned to Elan Pharmaceuticals, Inc, Method for increasing the bioavailability of metaxalone. US patent 6 407 128 B1. June 18, 2002.
8. American Society of Health-System Pharmacists. AHFS Drug Information 2001. Bethesda, MD: American Society of Health-System Pharmacists; 2001.